These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 35995846)

  • 21. Protocadherin 20 promotes ferroptosis by suppressing the expression of Sirtuin 1 and promoting the acetylation of nuclear factor erythroid 2-related factor 2 in hepatocellular carcinoma.
    Jun L; Chen W; Han L; Yanmin L; Qinglei Z; Pengfei Z
    Int J Biochem Cell Biol; 2023 Mar; 156():106363. PubMed ID: 36641129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1.
    He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L
    Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT/GPX4 pathway.
    Cai S; Zhang B; Huang C; Deng Y; Wang C; Yang Y; Xiang Z; Ni Y; Wang Z; Wang L; Zhang B; Guo X; He J; Ma K; Yu Z
    Cancer Lett; 2023 Nov; 579():216465. PubMed ID: 38084702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT.
    Tang J; Long G; Hu K; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
    Adv Sci (Weinh); 2023 Nov; 10(33):e2302953. PubMed ID: 37867237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
    Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
    Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m
    Wang H; Chen W; Cui Y; Gong H; Li H
    J Cell Mol Med; 2023 Dec; 27(24):4118-4132. PubMed ID: 37830241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Liu Y; Ouyang L; Mao C; Chen Y; Li T; Liu N; Wang Z; Lai W; Zhou Y; Cao Y; Liu S; Liang Y; Wang M; Liu S; Chen L; Shi Y; Xiao D; Tao Y
    Oncogene; 2022 Jul; 41(27):3570-3583. PubMed ID: 35688944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation.
    Wang Z; Shen N; Wang Z; Yu L; Yang S; Wang Y; Liu Y; Han G; Zhang Q
    Cell Death Differ; 2024 Jan; 31(1):53-64. PubMed ID: 37978273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UBAP2 contributes to radioresistance by enhancing homologous recombination through SLC27A5 ubiquitination in hepatocellular carcinoma.
    Liu Z; Yuan J; Zeng Q; Wu Z; Han J
    Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167481. PubMed ID: 39186963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and Prognostic Significance of Ferroptosis-related Proteins SLC7A11 and GPX4 in Renal Cell Carcinoma.
    Ren Z; Zhang X; Han J
    Protein Pept Lett; 2023; 30(10):868-876. PubMed ID: 37807410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).
    Bulatov E; Martin EM; Chatterjee S; Knebel A; Shimamura S; Konijnenberg A; Johnson C; Zinn N; Grandi P; Sobott F; Ciulli A
    J Biol Chem; 2015 Feb; 290(7):4178-91. PubMed ID: 25505247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
    Huang W; Chen K; Lu Y; Zhang D; Cheng Y; Li L; Huang W; He G; Liao H; Cai L; Tang Y; Zhao L; Pan M
    Neoplasia; 2021 Dec; 23(12):1227-1239. PubMed ID: 34768109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
    Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
    Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
    Zhang Y; Koppula P; Gan B
    Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11.
    Wang C; Liu H; Xu S; Deng Y; Xu B; Yang T; Liu W
    Cell Mol Neurobiol; 2023 Aug; 43(6):2627-2642. PubMed ID: 36988772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription.
    Wang YF; Feng JY; Zhao LN; Zhao M; Wei XF; Geng Y; Yuan HF; Hou CY; Zhang HH; Wang GW; Yang G; Zhang XD
    Acta Pharmacol Sin; 2023 Aug; 44(8):1712-1724. PubMed ID: 36829052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFNγ-mediated repression of system xc
    Kong R; Wang N; Han W; Bao W; Lu J
    J Leukoc Biol; 2021 Aug; 110(2):301-314. PubMed ID: 34318944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.
    Yao F; Zhou S; Zhang R; Chen Y; Huang W; Yu K; Yang N; Qian X; Tie X; Xu J; Zhang Y; Baheti T; Xu J; Dai X; Hao X; Zhang L; Wang X; Li Q
    Cancer Lett; 2024 Jul; 593():216935. PubMed ID: 38704136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation.
    Wang Y; Wang S; Zhang W
    Cell Cycle; 2023 May; 22(9):1116-1126. PubMed ID: 36809917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.